Not only metformin, but also D-allulose, alleviates metabolic disturbance and cognitive decline in prediabetic rats

References

• Hruby A, Hu FB. The epidemiology of obesity: a big picture. PharmacoEconomics. 2015;33:673–89.
   PubMed Web of Science ®Google Scholar
• Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10.
   PubMed Web of Science ®Google Scholar
• Hiltunen M, Khandelwal VK, Yaluri N, Tiilikainen T, Tusa M, Koivisto H, et al. Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med. 2012;16:1206–22.
   PubMed Web of Science ®Google Scholar
• Stranahan AM, Norman ED, Lee K, Cutler RG, Telljohann RS, Egan JM, et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus. 2008;18:1085–8.
   PubMed Web of Science ®Google Scholar
• Thambisetty M, Jeffrey Metter E, Yang A, Dolan H, Marano C, Zonderman AB, et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore longitudinal study of aging. JAMA Neurol. 2013;70:1167–72.
   PubMed Web of Science ®Google Scholar
• Pratchayasakul W, Kerdphoo S, Petsophonsakul P, Pongchaidecha A, Chattipakorn N, Chattipakorn SC. Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Sci. 2011;88:619–27.
   PubMed Web of Science ®Google Scholar
• Pintana H, Apaijai N, Chattipakorn N, Chattipakorn SC. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. J Endocrinol. 2013;218:1–11.
   PubMed Web of Science ®Google Scholar
• Chunchai T, Thunapong W, Yasom S, Wanchai K, Eaimworawuthikul S, Metzler G, et al. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats. J Neuroinflammation. 2018;15:11.
   PubMed Web of Science ®Google Scholar
• Pipatpiboon N, Pintana H, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur J Neurosci. 2013;37:839–49.
   PubMed Web of Science ®Google Scholar
• Pintana H, Apaijai N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sci. 2012;91:409–14.
   PubMed Web of Science ®Google Scholar
• Nyane NA, Tlaila TB, Malefane TG, Ndwandwe DE, Owira PMO. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: molecular and pharmacological insights. Eur J Pharmacol. 2017;803:103–11.
   PubMed Web of Science ®Google Scholar
• Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60:1586–93.
   PubMed Web of Science ®Google Scholar
• Araujo AA, Pereira A, Medeiros C, Brito GAC, Leitao RFC, Araujo LS, et al. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis. PLoS One. 2017;12:e0183506.
   PubMed Web of Science ®Google Scholar
• Chen D, Xia D, Pan Z, Xu D, Zhou Y, Wu Y, et al. Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. Cell Death Dis. 2016;7:e2441.
   PubMed Web of Science ®Google Scholar
• Vial G, Detaille D, Guigas B. Role of mitochondria in the mechanism(s) of action of metformin. Front Endocrinol. 2019;10:294.
   PubMed Web of Science ®Google Scholar
• Aksoz E, Gocmez SS, Sahin TD, Aksit D, Aksit H, Utkan T. The protective effect of metformin in scopolamine-induced learning and memory impairment in rats. Pharmacol Rep. 2019;71:818–25.
   PubMed Web of Science ®Google Scholar
• Farr SA, Roesler E, Niehoff ML, Roby DA, McKee A, Morley JE. Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer’s disease. J Alzheimers Dis. 2019;68:1699–710.
   PubMed Web of Science ®Google Scholar
• DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism. 2016;65:20–9.
   PubMed Web of Science ®Google Scholar
• Lalau JD, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N. Metformin-associated lactic acidosis (MALA): moving towards a new paradigm. Diabetes Obes Metab. 2017;19:1502–12.
   PubMed Web of Science ®Google Scholar
• Chung YM, Hyun Lee J, Youl Kim D, Hwang SH, Hong YH, Kim SB, et al. Dietary D-psicose reduced visceral fat mass in high-fat diet-induced obese rats. J Food Sci. 2012;77:H53–8.
   PubMed Web of Science ®Google Scholar
• Hossain A, Yamaguchi F, Matsunaga T, Hirata Y, Kamitori K, Dong Y, et al. Rare sugar D-psicose protects pancreas beta-islets and thus improves insulin resistance in OLETF rats. Biochem Biophys Res Commun. 2012;425:717–23.
   PubMed Web of Science ®Google Scholar
• Itoh K, Mizuno S, Hama S, Oshima W, Kawamata M, Hossain A, et al. Beneficial effects of supplementation of the rare sugar ‘D-allulose’ against hepatic steatosis and severe obesity in Lep(ob)/Lep(ob) mice. J Food Sci. 2015;80:H1619–26.
   PubMed Web of Science ®Google Scholar
• Saiyasit N, Chunchai T, Apaijai N, Pratchayasakul W, Sripetchwandee J, Chattipakorn N, et al. Chronic high-fat diet consumption induces an alteration in plasma/brain neurotensin signaling, metabolic disturbance, systemic inflammation/oxidative stress, brain apoptosis, and dendritic spine loss. Neuropeptides. 2020;82:102047.
   PubMed Web of Science ®Google Scholar
• Jinawong K, Apaijai N, Wongsuchai S, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. Necrostatin-1 mitigates cognitive dysfunction in prediabetic rats with no alteration in insulin sensitivity. Diabetes. 2020;69:1411–1423.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Chattipakorn SC, McMahon LL. Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices. J Neurophysiol. 2002;87:1515–25.
   PubMed Web of Science ®Google Scholar
• Pratchayasakul W, Sa-Nguanmoo P, Sivasinprasasn S, Pintana H, Tawinvisan R, Sripetchwandee J, et al. Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Horm Behav. 2015;72:68–77.
   PubMed Web of Science ®Google Scholar
• Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441–68.
   PubMed Web of Science ®Google Scholar
• Dheen ST, Kaur C, Ling EA. Microglial activation and its implications in the brain diseases. Curr Med Chem. 2007;14:1189–97.
   PubMed Web of Science ®Google Scholar
• Mendes NF, Kim YB, Velloso LA, Araujo EP. Hypothalamic microglial activation in obesity: a mini-review. Front Neurosci. 2018;12:846.
   PubMed Web of Science ®Google Scholar
• Chunchai T, Chattipakorn N, Chattipakorn SC. The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction. Metab Brain Dis. 2018;33:615–35.
   PubMed Web of Science ®Google Scholar
• Cope EC, LaMarca EA, Monari PK, Olson LB, Martinez S, Zych AD, et al. Microglia play an active role in obesity-associated cognitive decline. J Neurosci. 2018;38:8889–904.
   PubMed Web of Science ®Google Scholar
• Crews FT, Vetreno RP. Mechanisms of neuroimmune gene induction in alcoholism. Psychopharmacology. 2016;233:1543–57.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Sendo M, Dezaki K, Hira T, Sato T, Nakata M, et al. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nat Commun. 2018;9:113.
   PubMed Web of Science ®Google Scholar
• Tsukamoto I, Hossain A, Yamaguchi F, Hirata Y, Dong Y, Kamitori K, et al. Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose. Drug Des Devel Ther. 2014;8:1955–64.
   PubMed Web of Science ®Google Scholar
• Mooradian AD, Haas MJ, Onstead-Haas L, Tani Y, Iida T, Tokuda M. Naturally occurring rare sugars are free radical scavengers and can ameliorate endoplasmic reticulum stress. Int J Vitam Nutr Res. 2020;90:210–220.
   PubMedGoogle Scholar
• Jinpiao Z, Zongze Z, Qiuyue Y, Peng F, Qi Z, Yanlin W, et al. Metformin attenuates sevoflurane-induced neurocognitive impairment through AMPK-ULK1-dependent autophagy in aged mice. Brain Res Bull. 2020;157:18–25.
   PubMed Web of Science ®Google Scholar
• Singh RK, Gupta B, Tripathi K, Singh SK. Anti oxidant potential of metformin and pioglitazone in type 2 diabetes mellitus: beyond their anti glycemic effect. Diabetes Metab Syndr. 2016;10:102–4.
   PubMed Web of Science ®Google Scholar
• Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res. 2016;119:652–65.
   PubMed Web of Science ®Google Scholar
• Leech T, Chattipakorn N, Chattipakorn SC. The beneficial roles of metformin on the brain with cerebral ischaemia/reperfusion injury. Pharmacol Res. 2019;146:104261.
   PubMed Web of Science ®Google Scholar
• Lv WS, Wen JP, Li L, Sun RX, Wang J, Xian YX, et al. The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats. Brain Res. 2012;1444:11–9.
   PubMed Web of Science ®Google Scholar